Pressure Biosciences Inc (PBIO)

[namtae]

Fantasyland

If they reverse at 1 for 15 the float drops significantly...given revenue they already have, coupled with future revenue potential (given sales staff acquisition) they will trade on the Nas as a low-float, profitable, and growing company.

The RS will be more drastic than 1:15 to qualify for NASDAQ and leave some breathing room imo

The revenue they have today is insignificant and actually decreased in Q4

Future revenue (of significance) is only wishful thinking at this point or havent you heard that claim from PBIO enough

PBIOs potential low float works both ways. A small float (not so sure about that if you add the offering & convertible preferred) can see the share price rise OR FALL quickly. Remember the new shareholders coming on board have no loyalty to this stock

So yes, it just may be a low float company on NASDAQ but it is light years away from profitability and their limited growth to date, in terms of numbers, will not attract much interest from new investors